Covis Pharma Sàrl Mergers & Acquisitions

Covis Pharma Sàrl M&A Summary

Covis Pharma Sàrl has acquired 2 companies of its own, including 1 in the last 5 years.

Covis Pharma Sàrl’s largest acquisition to date was in 2020, when it acquired AMAG Pharmaceuticals for $647M. Covis Pharma Sàrl has acquired in 1 US state, and 2 countries. The Company’s most targeted sectors include life science (100%).

M&A Summary

  • M&A Total Activity2
    • M&A Buy Activity2
  • Total Sectors Invested 1
  • Total Countries Invested 2
  • M&A Buy/Sell Connections 1

Covis Pharma Sàrl

Bahnhofstrasse 11,
Luxembourg, CH-6300
Switzerland,
+44 (0)41 748 0401
www.covispharma.ch

All (2) Buy (2) Sell (-)
Date Target Value
$mlns
Transaction Type Acquirer Seller SRC
Link
2020-11-16 AMAG Pharmaceuticals, Inc. · Life Science
Waltham, Massachusetts · www.amagpharma.com

AMAG Pharmaceuticals, Inc. is a specialty pharmaceutical company that markets Feraheme (ferumoxytol) Injection and MuGard® Mucoadhesive Oral Wound Rinse. AMAG Pharmaceuticals was formed in 1981 and is based in Waltham, Massachusetts.

Revenue (mlns) 300 USD
Advisors: Goldman Sachs , Goodwin Procter
647
2.2x REVENUE
Add-on Acquisition

Covis Pharma Sàrl
Advisor: Paul, Weiss, Rifkind, Wharton & Garrison

-

Try Mergr Free — See This and 220,453+
Other Company and Investor Profiles Today

Try free. Full access. Cancel anytime.

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

Mergr is a user-friendly database designed to simplify the complex world of private equity and M&A for busy professionals.

We created Mergr to eliminate the challenge of tracking company acquisitions, sales, and ownership, providing clear insights into investment firms and their activities. For example, explore an investment firm’s investment criteria, deal history, portfolio, and connections - organized to help you uncover opportunities and make informed decisions.

With Mergr, gain access to a comprehensive, interconnected web of transactions, investors, companies, and advisors - all in one place.

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.8K Private Equity Firms
  • 214K M&A Transactions
  • 216K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.8K M&A Advisors
    (Investment Banks and Law Firms)
  • 82K M&A Contacts
    (PE and M&A Advisors)

What next?

Try Free

Full access to Mergr's investor, acquirer, and transaction data starts here.